Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both

doi:10.4254/wjh.v16.i6.871

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2210)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

1362

Figures (1-1)

211

Sum=1633

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

131

Download

203

Sum=334

Publishing Process of This Article

Item

Count

Browse

Download

103

Sum=160

Jun 27, 2024 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hepatol. Jun 27, 2024; 16(6): 871-877
Published online Jun 27, 2024. doi: 10.4254/wjh.v16.i6.871

Open in New Tab Full Size Figure Download Figure

Figure 1 Summary of relationship between sarcopenia and metabolic dysfunction associated steatotic liver disease. MASLD: Metabolic dysfunction associated steatotic liver disease.

Citation: Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. World J Hepatol 2024; 16(6): 871-877
URL: https://www.wjgnet.com/1948-5182/full/v16/i6/871.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i6.871